142 related articles for article (PubMed ID: 36583817)
1. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
[TBL] [Abstract][Full Text] [Related]
2. PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma.
Wang K; Luo L; Fu S; Wang M; Wang Z; Dong L; Wu X; Dai L; Peng Y; Shen G; Chen HN; Nice EC; Wei X; Huang C
Nat Commun; 2023 Feb; 14(1):1011. PubMed ID: 36823188
[TBL] [Abstract][Full Text] [Related]
3. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma.
Li Q; Qiu J; Yang H; Sun G; Hu Y; Zhu D; Deng Z; Wang X; Tang J; Jiang R
Cancer Lett; 2020 Jul; 482():112-125. PubMed ID: 31733289
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
[TBL] [Abstract][Full Text] [Related]
5. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells.
Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S
Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195
[TBL] [Abstract][Full Text] [Related]
6. OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1.
Yang Y; Jia S; Zhu N; Xiao X; Ma Y; Tu K; Guo Y; Xu Q
Biol Direct; 2024 Apr; 19(1):31. PubMed ID: 38658981
[TBL] [Abstract][Full Text] [Related]
7. High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer.
Jeon MJ; You MH; Han JM; Sim S; Yoo HJ; Lee WK; Kim TY; Song DE; Shong YK; Kim WG; Kim WB
Thyroid; 2020 Nov; 30(11):1625-1638. PubMed ID: 32438862
[No Abstract] [Full Text] [Related]
8. Glyceraldehyde-3-phosphate dehydrogenase promotes liver tumorigenesis by modulating phosphoglycerate dehydrogenase.
Liu S; Sun Y; Jiang M; Li Y; Tian Y; Xue W; Ding N; Sun Y; Cheng C; Li J; Miao X; Liu X; Zheng L; Huang K
Hepatology; 2017 Aug; 66(2):631-645. PubMed ID: 28387968
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinating enzyme JOSD2 promotes hepatocellular carcinoma progression through interacting with and inhibiting CTNNB1 degradation.
Huang Y; Zeng J; Liu T; Xu Q; Song X; Zeng J
Cell Biol Int; 2022 Jul; 46(7):1089-1097. PubMed ID: 35568970
[TBL] [Abstract][Full Text] [Related]
10. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
Cells; 2020 May; 9(5):. PubMed ID: 32408542
[TBL] [Abstract][Full Text] [Related]
11. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
Ma X; Li B; Liu J; Fu Y; Luo Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
[TBL] [Abstract][Full Text] [Related]
12. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
13. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
14. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP.
Tian Z; Xu C; He W; Lin Z; Zhang W; Tao K; Ding R; Zhang X; Dou K
Cancer Lett; 2023 Nov; 577():216439. PubMed ID: 37832781
[TBL] [Abstract][Full Text] [Related]
16. Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate.
Wu YQ; Zhang CS; Xiong J; Cai DQ; Wang CZ; Wang Y; Liu YH; Wang Y; Li Y; Wu J; Wu J; Lan B; Wang X; Chen S; Cao X; Wei X; Hu HH; Guo H; Yu Y; Ghafoor A; Xie C; Wu Y; Xu Z; Zhang C; Zhu M; Huang X; Sun X; Lin SY; Piao HL; Zhou J; Lin SC
Cell Res; 2023 Nov; 33(11):835-850. PubMed ID: 37726403
[TBL] [Abstract][Full Text] [Related]
17. USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1.
Wu Q; Qiu Y; Guo J; Yuan Z; Yang Y; Zhu Q; Zhang Z; Guo J; Wu Y; Zhang J; Huang D; Tu K; Hu X
Biol Direct; 2024 Feb; 19(1):13. PubMed ID: 38308285
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1.
Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J
Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571
[TBL] [Abstract][Full Text] [Related]
19. Oxytetracycline have the therapeutic efficiency in CD133
Song Y; Kim IK; Choi I; Kim SH; Seo HR
Sci Rep; 2018 Oct; 8(1):16100. PubMed ID: 30382122
[TBL] [Abstract][Full Text] [Related]
20. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
